These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32888873)

  • 1. Prognostic importance of Kidney, Heart and Interstitial lung diseases (KHI triad) in PH: A machine learning study.
    Fauvel C; Raitière O; Belkacem NS; Dominique S; Artaud-Macari E; Viacroze C; Schleifer D; Bauer F
    Arch Cardiovasc Dis; 2020 Oct; 113(10):630-641. PubMed ID: 32888873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
    Awerbach JD; Stackhouse KA; Lee J; Dahhan T; Parikh KS; Krasuski RA
    Respir Med; 2019 Apr; 150():126-130. PubMed ID: 30961938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.
    Sweatt AJ; Hedlin HK; Balasubramanian V; Hsi A; Blum LK; Robinson WH; Haddad F; Hickey PM; Condliffe R; Lawrie A; Nicolls MR; Rabinovitch M; Khatri P; Zamanian RT
    Circ Res; 2019 Mar; 124(6):904-919. PubMed ID: 30661465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
    Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
    Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
    Rose L; Prins KW; Archer SL; Pritzker M; Weir EK; Misialek JR; Thenappan T
    J Heart Lung Transplant; 2019 Feb; 38(2):145-155. PubMed ID: 30391191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of post-operative cardiovascular events, focused on atrial fibrillation, after valve surgery for primary mitral regurgitation.
    Pimor A; Galli E; Vitel E; Corbineau H; Leclercq C; Bouzille G; Donal E
    Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):177-184. PubMed ID: 29608669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.
    Hedman ÅK; Hage C; Sharma A; Brosnan MJ; Buckbinder L; Gan LM; Shah SJ; Linde CM; Donal E; Daubert JC; Mälarstig A; Ziemek D; Lund L
    Heart; 2020 Mar; 106(5):342-349. PubMed ID: 31911501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.
    Alushi B; Beckhoff F; Leistner D; Franz M; Reinthaler M; Stähli BE; Morguet A; Figulla HR; Doenst T; Maisano F; Falk V; Landmesser U; Lauten A
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):591-601. PubMed ID: 29680341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.
    Xanthouli P; Koegler M; Marra AM; Benjamin N; Fischer L; Eichstaedt CA; Harutyunova S; Nagel C; Grünig E; Egenlauf B
    Respir Res; 2020 May; 21(1):127. PubMed ID: 32448256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
    Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
    J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry.
    Hoeper MM; Pausch C; Grünig E; Klose H; Staehler G; Huscher D; Pittrow D; Olsson KM; Vizza CD; Gall H; Benjamin N; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Rosenkranz S; Ewert R; Kaemmerer H; Lange TJ; Kabitz HJ; Skowasch D; Skride A; Jureviciene E; Paleviciute E; Miliauskas S; Claussen M; Behr J; Milger K; Halank M; Wilkens H; Wirtz H; Pfeuffer-Jovic E; Harbaum L; Scholtz W; Dumitrescu D; Bruch L; Coghlan G; Neurohr C; Tsangaris I; Gorenflo M; Scelsi L; Vonk-Noordegraaf A; Ulrich S; Held M
    J Heart Lung Transplant; 2020 Dec; 39(12):1435-1444. PubMed ID: 33082079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.
    Wijeratne DT; Lajkosz K; Brogly SB; Lougheed MD; Jiang L; Housin A; Barber D; Johnson A; Doliszny KM; Archer SL
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e003973. PubMed ID: 29444925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
    Frank AL; Kreuter M; Schwarzkopf L
    Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
    Ooi C; Solanki K; Lao C; Frampton C; White D
    Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrecognized pulmonary arterial hypertension in hospitalized patients.
    Carpio AM; Goertz A; Kelly C; Willes L; Quan SF; Pressman GS; Niroula A; Sharma S
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1237-1243. PubMed ID: 33211240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.